BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16326273)

  • 1. Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme.
    Chang CY; Li MC; Liao SL; Huang YL; Shen CC; Pan HC
    J Clin Neurosci; 2005 Nov; 12(8):930-3. PubMed ID: 16326273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible cyclooxygenase (COX-2) in glioblastoma--clinical and immunohistochemical (COX-2-VEGF) correlations.
    Buccoliero AM; Caldarella A; Gheri CF; Taddei A; Paglierani M; Pepi M; Mennonna P; Taddei GL
    Clin Neuropathol; 2006; 25(2):59-66. PubMed ID: 16550738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
    Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
    Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic value of glycosyltransferase mRNA in glioblastoma multiforme patients.
    Oblinger JL; Pearl DK; Boardman CL; Saqr H; Prior TW; Scheithauer BW; Jenkins RB; Burger PC; Yates AJ
    Neuropathol Appl Neurobiol; 2006 Aug; 32(4):410-8. PubMed ID: 16866986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Increased amounts of IL-10 mRNA in anaplastic astrocytomas and glioblastoma multiforme].
    Huettner C; Paulus W; Roggendorf W
    Verh Dtsch Ges Pathol; 1994; 78():418-22. PubMed ID: 7534012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue.
    Hunter SB; Varma V; Shehata B; Nolen JD; Cohen C; Olson JJ; Ou CY
    J Histochem Cytochem; 2005 Aug; 53(8):963-9. PubMed ID: 16055749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic effect of brain-specific angiogenesis inhibitor 1 on glioblastoma: an animal experiment].
    Xiao XR; Kang XX; Zhao JZ
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(19):1342-6. PubMed ID: 16796906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the prognostic value of CD44 in glioblastoma multiforme.
    Wei KC; Huang CY; Chen PY; Feng LY; Wu TW; Chen SM; Tsai HC; Lu YJ; Tsang NM; Tseng CK; Pai PC; Shin JW
    Anticancer Res; 2010 Jan; 30(1):253-9. PubMed ID: 20150644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas.
    Colin C; Voutsinos-Porche B; Nanni I; Fina F; Metellus P; Intagliata D; Baeza N; Bouvier C; Delfino C; Loundou A; Chinot O; Lah T; Kos J; Martin PM; Ouafik L; Figarella-Branger D
    Acta Neuropathol; 2009 Dec; 118(6):745-54. PubMed ID: 19774387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas.
    Huettner C; Paulus W; Roggendorf W
    Am J Pathol; 1995 Feb; 146(2):317-22. PubMed ID: 7856743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling prognosis for patients with malignant astrocytic gliomas: quantifying the expression of multiple genetic markers and clinical variables.
    Zhou YH; Hess KR; Liu L; Linskey ME; Yung WK
    Neuro Oncol; 2005 Oct; 7(4):485-94. PubMed ID: 16212813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.
    Kuan CT; Wakiya K; Dowell JM; Herndon JE; Reardon DA; Graner MW; Riggins GJ; Wikstrand CJ; Bigner DD
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1970-82. PubMed ID: 16609006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and structure of interleukin 4 receptor (IL-4R) complex in human invasive pituitary adenomas.
    Chen L; Liu Y; Hou Y; Kato Y; Sano H; Kanno T
    Neurosci Lett; 2007 Apr; 417(1):30-5. PubMed ID: 17398005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients.
    Wang LF; Fokas E; Bieker M; Rose F; Rexin P; Zhu Y; Pagenstecher A; Engenhart-Cabillic R; An HX
    Oncol Rep; 2008 Jan; 19(1):151-6. PubMed ID: 18097589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
    Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
    Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: an unexpected prognostic significance?
    Kren L; Slaby O; Muckova K; Lzicarova E; Sova M; Vybihal V; Svoboda T; Fadrus P; Lakomy R; Vanhara P; Krenova Z; Sterba J; Smrcka M; Michalek J
    Neuropathology; 2011 Apr; 31(2):129-34. PubMed ID: 20667016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.
    Reddy SP; Britto R; Vinnakota K; Aparna H; Sreepathi HK; Thota B; Kumari A; Shilpa BM; Vrinda M; Umesh S; Samuel C; Shetty M; Tandon A; Pandey P; Hegde S; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Kondaiah P; Somasundaram K; Rao MR
    Clin Cancer Res; 2008 May; 14(10):2978-87. PubMed ID: 18483363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ki-67 expression in operable breast cancer: a comparative study of immunostaining and a real-time RT-PCR assay.
    Potemski P; Pluciennik E; Bednarek AK; Kusinska R; Kubiak R; Jesionek-Kupnicka D; Watala C; Kordek R
    Pathol Res Pract; 2006; 202(7):491-5. PubMed ID: 16678980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of c-Met expression in glioblastomas.
    Kong DS; Song SY; Kim DH; Joo KM; Yoo JS; Koh JS; Dong SM; Suh YL; Lee JI; Park K; Kim JH; Nam DH
    Cancer; 2009 Jan; 115(1):140-8. PubMed ID: 18973197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures.
    Joshi BH; Leland P; Asher A; Prayson RA; Varricchio F; Puri RK
    Cancer Res; 2001 Nov; 61(22):8058-61. PubMed ID: 11719427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.